Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial
Nom du journal : ESMO Open
Année : 2021
Volume : 7
Page de départ : 100340